Xue-yan Kui
Shiyan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
Journal: Frontiers in endocrinology
Published: August 06, 2022
High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA.
Journal: Journal of translational medicine
Published: May 24, 2022
SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Journal: Frontiers in cell and developmental biology
Published: January 12, 2022
Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma.
Journal: Frontiers in genetics
Published: December 15, 2021
Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: November 05, 2021
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Journal: Frontiers in immunology
Published: July 31, 2021
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Journal: Frontiers in immunology
Published: June 14, 2021
Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma.
Journal: Frontiers in oncology
Published: February 10, 2021
18F-FDG PET/CT metabolic parameters correlate with EIF2S2 expression status in colorectal cancer.
Journal: Journal of Cancer
Published: January 07, 2021
Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
Journal: Frontiers in oncology
Published: September 16, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026